High triglycerides linked to prostate cancer recurrence

Researchers from the US have found that among men with dyslipidaemia, elevated cholesterol and HDL levels were associated with increased and decreased risk of recurrence respectively.

Associate professor of surgery at Duke University’s School of Medicine, Stephen Freedland, and colleagues reviewed data from 843 men who underwent radical prostatectomy after a prostate cancer diagnosis and who never took statins before surgery.

Fasting total serum cholesterol, LDL, HDL and triglyceride levels were measured within the year before the men underwent surgery.

Among men with dyslipidaemia, those who had serum triglyceride levels of 150mg/dL or higher had a 35% increased risk for prostate cancer recurrence when compared with patients who had normal levels of triglycerides.

What’s more, for every 10mg/dL increase in total serum cholesterol above 200mg/dL, there was a 9% increased risk for prostate cancer recurrence.